Literature DB >> 2242609

Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin.

J A Aarli1, K Stefansson, L S Marton, R L Wollmann.   

Abstract

Patients with myasthenia gravis (MG) and thymoma have in their sera antibodies which react with non-receptor antigens from striated muscle. The purpose of this investigation was to characterize the antigen(s). Polypeptides in homogenates from rat skeletal muscle were separated by SDS-PAGE and trans-blotted to nitrocellulose. Sera from six patients with MG and thymoma stained a large (molecular weight greater than 500 kD) polypeptide, while no staining was observed with sera from 20 non-thymoma MG patients. Titin is one of the large (greater than 500 kD) polypeptides of striated muscle and the antibody containing MG sera have antibodies that bind to titin in a preparation of myofibrillary proteins from rabbit skeletal muscle. The staining pattern is identical to that obtained with antiserum to titin, showing that the antigen has the same electrophoretic mobility as titin. Antibodies from the sera of the patients with MG and thymoma, affinity-purified on the large polypeptide, reacted with skeletal muscle sections in a cross-striational pattern, near the A/I band junction but within the I band, corresponding to the localization of one of the epitopes of titin. Our findings therefore indicate that the muscle antibodies found in the sera from some MG patients with thymoma are directed against titin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242609      PMCID: PMC1535140          DOI: 10.1111/j.1365-2249.1990.tb05440.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Studies on autoantibodies in myasthenia gravis.

Authors:  E H BEUTNER; E WITEBSKY; D RICKEN; R H ADLER
Journal:  JAMA       Date:  1962-10-06       Impact factor: 56.272

2.  Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.

Authors:  A K Lefvert; K Bergström; G Matell; P O Osterman; R Pirskanen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis.

Authors:  J Peers; B L McDonald; R L Dawkins
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

5.  Serum autoantibodies in myasthenia gravis and thymoma: selective affinity for I-bands of striated muscle as a guide to identification of antigen(s).

Authors:  A J Strauss; P G Kemp
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

6.  Muscle antibodies in myasthenia gravis.

Authors:  J M Vetters
Journal:  Immunology       Date:  1967-09       Impact factor: 7.397

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Immunofluorescence staining patterns in skeletal muscle using serum of myasthenic patients and normal controls.

Authors:  J M Vetters
Journal:  Immunology       Date:  1965-07       Impact factor: 7.397

9.  Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination.

Authors:  J A Aarli; A K Lefvert; O Tönder
Journal:  J Neuroimmunol       Date:  1981-12       Impact factor: 3.478

10.  Mechanisms of acetylcholine receptor loss in myasthenia gravis.

Authors:  D B Drachman; R N Adams; E F Stanley; A Pestronk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

View more
  17 in total

Review 1.  Autoantigens in systemic autoimmunity: critical partner in pathogenesis.

Authors:  A Rosen; L Casciola-Rosen
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

2.  Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma.

Authors:  E K Lee; R A Maselli; W G Ellis; M A Agius
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

3.  A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.

Authors:  N Nagvekar; A M Moody; P Moss; I Roxanis; J Curnow; D Beeson; N Pantic; J Newsom-Davis; A Vincent; N Willcox
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis.

Authors:  A Marx; A Wilisch; A Schultz; A Greiner; B Magi; V Pallini; B Schalke; K Toyka; W Nix; T Kirchner; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

5.  A shared epitope in the acetylcholine receptor-alpha subunit and fast troponin I of skeletal muscle. Is it important for myasthenia gravis?

Authors:  M Osborn; A Marx; T Kirchner; S J Tzartos; U Plessman; K Weber
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

6.  Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.

Authors:  A Mygland; J A Aarli; R Matre; N E Gilhus
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

7.  Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.

Authors:  Anette S B Wolff; Jaanika Kärner; Jone F Owe; Bergithe E V Oftedal; Nils Erik Gilhus; Martina M Erichsen; Olle Kämpe; Anthony Meager; Pärt Peterson; Kai Kisand; Nick Willcox; Eystein S Husebye
Journal:  J Immunol       Date:  2014-09-17       Impact factor: 5.422

8.  Thymoma in myasthenia gravis: from diagnosis to treatment.

Authors:  Fredrik Romi
Journal:  Autoimmune Dis       Date:  2011-08-10

9.  Three types of striational antibodies in myasthenia gravis.

Authors:  Shigeaki Suzuki; Kimiaki Utsugisawa; Yuriko Nagane; Norihiro Suzuki
Journal:  Autoimmune Dis       Date:  2011-07-17

10.  Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays.

Authors:  Anne Becker; Nicole Ludwig; Andreas Keller; Björn Tackenberg; Christian Eienbröker; Wolfgang H Oertel; Klaus Fassbender; Eckart Meese; Klemens Ruprecht
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.